An fitar da allurar rigakafin mRNA a duniya a farkon 2021 tare da taken 'lafiya da inganci.' Ba a saba ba don sabon nau'in magani, ba da daɗewa ba hukumomin kiwon lafiyar jama'a suka ba da shawarar su ga mata masu juna biyu.
Ya zuwa karshen shekarar 2021, matan da suka kai shekarun aiki, ciki har da masu ciki, ana korarsu daga aiki saboda ba su yarda a yi musu allura ba. Wadanda suka dauki allurar mRNA sun yi hakan ne bisa dogaro ga hukumomin kiwon lafiya - tsammanin cewa ba za a amince da su ba idan shaidar ba ta bayyana sarai ba. Matsayin hukumomin gudanarwa shine kare jama'a kuma, sabili da haka, idan an amince da su, "alurar rigakafi" sun kasance lafiya.
Kwanan nan, wani dogon rahoton kimanta alluran rigakafin da Pfizer ya ɗauki nauyin kuma aka ƙaddamar da shi ga mai kula da Ostiraliya, Hukumar Kula da Kaya ta Therapeutic (TGA) mai kwanan watan Janairu 2021 ya kasance. saki a ƙarƙashin buƙatar 'Yancin Bayanai.
Rahoton ya ƙunshi sabbin bayanai masu mahimmanci waɗanda TGA da Pfizer kanta suka danne. Yawancin wannan yana da alaƙa kai tsaye da batun aminci a cikin ciki, kuma yana tasiri akan haifuwar matan da suka kai shekarun haihuwa. Dukkan rahoton yana da mahimmanci, amma mahimman bayanai guda huɗu sun fito fili;
- Saurin raguwa a cikin ƙwayoyin rigakafi da ƙwayoyin T a cikin birai bayan kashi na biyu,
- Nazarin rarraba halittu (wanda aka fitar a baya a cikin 2021 ta hanyar buƙatun FOI a Japan)
- Bayanai kan tasirin sakamakon haihuwa ga berayen.
- Bayanai kan rashin daidaituwar tayi a cikin berayen.
Mun mayar da hankali kan abubuwa uku na ƙarshe kamar yadda, don batu na farko, ya isa a faɗi rahoton da kansa "Antibodies da T cells a cikin birai sun ƙi da sauri sama da makonni 5 bayan kashi na biyu na BNT162b2 (V9), yana haifar da damuwa game da rigakafi na dogon lokaci...".
Wannan batu yana nuna cewa yakamata masu gudanarwa suyi tsammanin raguwar inganci cikin sauri kuma dole ne su sani tun da farko cewa farkon kashi biyu na "hass" ba shi da yuwuwa ya ba da rigakafi mai ɗorewa kuma, don haka, yana buƙatar maimaita allurai. Dr Anthony Fauci, tsohon darekta a NIH ta Amurka ya bayyana wannan tsammanin gazawar kwanan nan.
Abubuwan da suka rage ya kamata su zama babban dalilin ƙararrawa tare da tsarin sarrafa magunguna. Na farko, kamar saukar a cikin 2021, ya haɗa da nazarin rarrabawar halittu na mai ɗaukar nanoparticle mai lipid a cikin berayen, ta amfani da enzyme luciferase don maye gurbin maganin mRNA.
Binciken ya nuna cewa maganin zai yi tafiya a cikin jiki bayan allura, kuma ana samunsa ba kawai a wurin allurar ba, amma a cikin dukkanin gabobin da aka gwada, tare da maida hankali sosai a cikin ovaries, hanta, glandan adrenal, da kuma safiya. Hukumomin da suka tabbatar wa mutanen da aka yi wa allurar a farkon shekarar 2021 cewa maganin ya tsaya a hannu, kamar yadda muka sani shekaru biyu, karya ne.
Matsakaicin lipid a kowace gram, ana sake ƙididdige shi azaman adadin wurin allura.
| ORGAN | 48 HOURS µg lipid equiv/g | TOTAL | SHAFIN INJECIN CONC VS |
| ADRENAL | 18.21 | 164.9 | 11.04% |
| MARROW | 3.77 | 164.9 | 2.29% |
| site | 164.9 | 164.9 | 100.00% |
| HANTA | 24.29 | 164.9 | 14.73% |
| OVARIES | 12.26 | 164.9 | 7.43% |
| Spleten | 23.35 | 164.9 | 14.16% |
Dangane da tasirin tasirin haihuwa da rashin daidaituwa na tayin, rahoton ya haɗa da nazarin berayen 44 kuma ya bayyana manyan ma'auni guda biyu, yawan asarar da aka riga aka dasa da kuma yawan rashin daidaituwa ga tayin (wanda kuma aka bayyana a kowace litter). A lokuta biyu ma'auni sun fi girma ga berayen da aka yi wa alurar riga kafi fiye da na berayen da ba a yi musu allurar ba.
Kusan magana, rabon asarar da aka yi kafin shukawa ya kwatanta kiyasin adadin da aka samu takin ova da kuma ova da aka dasa a cikin mahaifa. Teburin da ke ƙasa an ɗauke shi daga rahoton da kansa kuma yana nuna a sarari adadin asarar da aka yi wa alurar riga kafi (BNT162b2) ya ninka fiye da ninki biyu na ƙungiyar kulawa da ba a yi ba.
A cikin binciken kula da shari'ar, ninka asarar ciki a cikin ƙungiyar sa baki zai wakilci siginar aminci mai tsanani. Maimakon ɗaukar wannan da mahimmanci, marubutan rahoton sun kwatanta sakamakon da bayanan tarihi akan sauran al'ummomin beraye; Nazarin 27 na berayen 568, kuma sun yi watsi da sakamakon saboda sauran jama'a sun sami asarar gaba ɗaya; Ana nuna wannan kewayon a shafi na hannun dama kamar kashi 2.6 zuwa kashi 13.8. Wannan bincike yana da ban tsoro yayin da ya rage a ƙasa mafi girman matakan asarar ciki da aka rubuta a baya a cikin jama'a a wasu wurare ba kyakkyawan sakamako ba ne lokacin da sa baki kuma yana da alaƙa da cutarwa sau biyu na ƙungiyar kulawa.
Ana lura da irin wannan tsari don lalacewar tayin tare da mafi girman rashin daidaituwa a cikin kowane nau'i 12 da aka yi nazari. Daga cikin nau'o'in 11 inda Pfizer ya tabbatar da cewa bayanan daidai ne, akwai kawai 2 na rashin daidaituwa a cikin rukunin kulawa, sabanin. 28 tare da maganin mRNA (BNT162b2). A cikin nau'in wanda Pfizer ya lakafta a matsayin wanda ba a iya dogara da shi ba (mafi yawan haƙarƙari na lumbar), akwai rashin daidaituwa 3 a cikin ƙungiyar kulawa da 12 a cikin ƙungiyar da aka yi wa alurar riga kafi.
Kamar yadda yake tare da karuwar asarar ciki, Pfizer kawai yayi watsi da yanayin kuma ya kwatanta sakamakon tare da bayanan tarihi daga sauran al'ummomin bera. Wannan yana da mahimmanci kamar yadda ake gani a kowane nau'i na rashin lafiya. An sake yin watsi da yanayin sarrafa yanayin ƙirar binciken, domin a bayyane yake ɓoye mummunan sakamakon da aka nuna.
Wadannan bayanan sun nuna cewa babu wani dalili na cewa maganin ba shi da lafiya a cikin ciki. Ƙaddamar da LNPs a cikin ovaries, yawan asarar ciki ninki biyu, da haɓaka ƙimar tayin tayi a duk nau'ikan da aka auna yana nuna cewa zayyana alamar lafiya-cikin ciki (nau'in B1 a Ostiraliya) ya saba wa samuwan shaida. Bayanan na nuni da cewa ba wai kawai kalmar "lafiya da inganci" na Gwamnati ba daidai ba ne, yaudara ce gaba daya dangane da bayanan amincin da ke akwai.
Abubuwan da ba a sani ba da bayanan da suka ɓace:
Duk da mummunan yanayin waɗannan sakamakon, rarraba wannan magani a matsayin maganin rigakafi ya bayyana ya hana ƙarin gwajin dabbobi. A tarihi, sabbin magunguna, musamman a azuzuwan da ba a taɓa amfani da su ba a cikin ɗan adam a da, na buƙatar ƙima sosai. Alluran rigakafi, duk da haka, suna da ƙanƙan nauyin shaidar da ake buƙata fiye da na yau da kullun. Ta hanyar rarraba alluran mRNA a matsayin "alurar rigakafi," wannan ya tabbatar da amincewar tsari tare da ƙarancin buƙatun aminci mai mahimmanci, kamar yadda TGA kanta ta lura.
A zahiri, hanyoyin kwantar da hankali na mRNA suna aiki kamar magunguna fiye da alluran rigakafi ta yadda suke canza aikin cikin sel, maimakon ƙarfafa martanin rigakafi ga kasancewar antigen. Lakabi waɗannan samfuran maganin ƙwayoyin cuta a matsayin alluran rigakafi yana nufin, kamar yadda muka sani, ko da a yau ba a gudanar da nazarin ƙwayoyin cuta ko ƙwayar cuta ba.
Wannan rahoton, wanda aka fitar kawai bayan buƙatar FOI, yana da matukar tayar da hankali yayin da yake nuna cewa hukumomi sun san manyan haɗari tare da rigakafin mRNA Covid-19 yayin da suke ba da tabbacin jama'a a lokaci guda. Gaskiyar cewa kafofin watsa labarai na yau da kullun (kamar yadda muka sani) sun yi watsi da sabbin bayanan da aka fitar gaba ɗaya yakamata ya ƙarfafa buƙatar taka tsantsan yayin sauraron shawarar saƙon lafiyar jama'a game da rigakafin Covid-19.
Da fari dai, a bayyane yake cewa masu mulki, kamfanonin magunguna da gwamnati za su san cewa rigakafi da ke haifar da rigakafi yana tafiya cikin sauri tare da lura da hakan a cikin bayanan duniya na ainihi tare da tasiri kan kamuwa da cuta faduwa zuwa sifili. Dangane da haka, batu guda a cikin alkalumman lokaci na kashi 95 cikin 62 da ingancin kashi XNUMX cikin XNUMX a kan lamuran nakalto na Pfizer da ChAdOx1 (AstraZeneca) kusan babu komai tunda ana tsammanin raguwa cikin sauri.
Hakazalika, manufar "kwas" na kashi biyu ba daidai ba ne saboda da alama ana buƙatar masu haɓakawa marasa iyaka idan aka yi la'akari da saurin raguwar ƙwayoyin rigakafi da ƙwayoyin T-sel a cikin birai.
Mafi mahimmanci, bayanan ba ta kowace hanya ta goyi bayan ƙarshen "lafiya" game da ciki; Ƙarshen haɗari zai zama mafi daidai. Tabbacin amincin ya kasance, don haka, gaba ɗaya ɓata ne idan aka yi la'akari da bayanan da aka fitar a cikin 'yancin bayanan kwanan nan.
Hukumomin gudanarwa sun san cewa binciken dabbobi ya nuna manyan tutoci masu ja game da asarar ciki da kuma rashin daidaituwar tayi, daidai da tsarin rarraba mRNA da suke ɓoyewa ga jama'a.
Ko a cikin Maris 2023, ba zai yuwu a ba da waɗannan tabbacin ba, ganin cewa ba a yi nazarin mahimman bayanai ba, gwargwadon iliminmu.
Pfizer ya zaɓi kada ya bi diddigin yawancin masu juna biyu a farkon gwajin ɗan adam, duk da yawan zubar da ciki a cikin tsirarun da suka biyo baya. Ganin duk matsalolin da ke tattare da inganci da aminci, gudanar da waɗannan samfuran ga matan da suka kai shekarun haihuwa, da gudanarwa ga mata masu juna biyu masu lafiya suna da haɗari kuma ba daidai ba ne.
Taimakawa cikin haɗin gwiwar marubucin wannan maƙala shine Alex Kriel, masanin kimiyyar lissafi kuma yana ɗaya daga cikin mutanen farko da suka fara nuna kuskuren tsarin Imperial COVID, kuma shine wanda ya kafa Haɗin gwiwar Tunani wanda ya ƙunshi gungun ƴan ƙasa da suka damu da wuce gona da iri da Gwamnati ke yi.
-
David Bell, Babban Masanin Kimiyya a Cibiyar Brownstone, likitan lafiyar jama'a ne kuma mai ba da shawara kan ilimin halittu a cikin lafiyar duniya. David tsohon jami'in kiwon lafiya ne kuma masanin kimiyya a Hukumar Lafiya ta Duniya (WHO), Shugaban Shirin Malaria da cututtukan zazzabi a Gidauniyar Innovative New Diagnostics (FIND) a Geneva, Switzerland, kuma Daraktan Fasahar Kiwon Lafiya ta Duniya a Asusun Kula da Lafiya na Duniya na Intellectual Ventures a Bellevue, WA, Amurka.
Duba dukkan posts
